BALMER LAWRIE & COMPANY
|
BALMER LAWRIE & COMPANY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 16.18 | 15.55 | 13.53 | 9.56 | 7.84 |
| CEPS(Rs) | 16.29 | 14.92 | 15.11 | 9.57 | 8.49 |
| DPS(Rs) | 8.50 | 8.50 | 8.50 | 7.50 | 6.50 |
| Book NAV/Share(Rs) | 120.99 | 115.12 | 106.48 | 98.29 | 92.81 |
| Tax Rate(%) | 29.62 | 29.36 | 27.39 | 34.96 | 34.80 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.48 | 12.18 | 11.54 | 8.13 | 7.86 |
| EBIT Margin(%) | 11.82 | 12.02 | 12.68 | 7.85 | 7.28 |
| Pre Tax Margin(%) | 10.59 | 10.96 | 11.73 | 7.08 | 6.62 |
| PAT Margin (%) | 7.45 | 7.74 | 8.52 | 4.60 | 4.32 |
| Cash Profit Margin (%) | 10.25 | 10.14 | 11.05 | 7.05 | 7.07 |
| Performance Ratios | |||||
| ROA(%) | 6.34 | 6.59 | 7.20 | 4.19 | 3.68 |
| ROE(%) | 10.03 | 10.28 | 11.38 | 6.54 | 5.67 |
| ROCE(%) | 15.33 | 15.34 | 16.17 | 10.56 | 9.02 |
| Asset Turnover(x) | 0.85 | 0.85 | 0.85 | 0.91 | 0.85 |
| Sales/Fixed Asset(x) | 2.27 | 2.35 | 2.26 | 2.30 | 2.09 |
| Working Capital/Sales(x) | 3.04 | 2.85 | 3.03 | 3.35 | 2.98 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.44 | 0.43 | 0.44 | 0.44 | 0.48 |
| Receivable days | 68.08 | 65.70 | 61.46 | 53.09 | 53.48 |
| Inventory Days | 24.28 | 28.00 | 31.07 | 31.91 | 32.06 |
| Payable days | 66.29 | 67.57 | 73.19 | 64.88 | 69.24 |
| Valuation Parameters | |||||
| PER(x) | 9.22 | 11.88 | 17.64 | 11.59 | 14.39 |
| PCE(x) | 9.16 | 12.38 | 15.80 | 11.58 | 13.27 |
| Price/Book(x) | 1.23 | 1.60 | 2.24 | 1.13 | 1.21 |
| Yield(%) | 5.70 | 4.60 | 3.56 | 6.77 | 5.76 |
| EV/Net Sales(x) | 0.80 | 1.10 | 1.55 | 0.66 | 0.78 |
| EV/Core EBITDA(x) | 5.47 | 7.66 | 10.22 | 6.43 | 7.79 |
| EV/EBIT(x) | 6.77 | 9.18 | 12.26 | 8.43 | 10.74 |
| EV/CE(x) | 1.01 | 1.36 | 1.92 | 0.87 | 0.66 |
| M Cap / Sales | 0.94 | 1.26 | 1.75 | 0.82 | 0.94 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.00 | 7.54 | 0.76 | 12.95 | 34.43 |
| Core EBITDA Growth(%) | 9.53 | 1.94 | 48.80 | 15.95 | 8.67 |
| EBIT Growth(%) | 6.20 | 1.95 | 62.70 | 21.81 | 11.08 |
| PAT Growth(%) | 3.90 | -2.25 | 86.49 | 20.50 | 7.39 |
| EPS Growth(%) | 4.00 | 14.91 | 41.63 | 21.96 | 16.22 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 |
| Current Ratio(x) | 2.13 | 2.27 | 2.08 | 2.08 | 2.31 |
| Quick Ratio(x) | 1.92 | 1.99 | 1.81 | 1.76 | 1.93 |
| Interest Cover(x) | 9.59 | 11.40 | 13.45 | 10.16 | 11.01 |
| Total Debt/Mcap(x) | 0.03 | 0.02 | 0.02 | 0.05 | 0.05 |
Compare Financial Ratios of peers of BALMER LAWRIE & COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALMER LAWRIE & COMPANY | ₹2,812.1 Cr | -5.2% | -2.7% | -24% | Stock Analytics | |
| GRASIM INDUSTRIES | ₹217,105.0 Cr | -0.7% | 0.7% | 18.4% | Stock Analytics | |
| 3M INDIA | ₹35,594.8 Cr | -0.8% | -9.7% | 6.3% | Stock Analytics | |
| DCM SHRIRAM | ₹15,540.4 Cr | -1.2% | -1.1% | -19% | Stock Analytics | |
| HINDUSTAN FOODS | ₹7,254.6 Cr | -1.6% | 3.5% | 15.6% | Stock Analytics | |
| TTK HEALTHCARE | ₹1,518.6 Cr | 2.4% | -2.1% | -3.3% | Stock Analytics | |
BALMER LAWRIE & COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALMER LAWRIE & COMPANY | -5.2% |
-2.7% |
-24% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses
